Related Experiment Video
Updated: Jan 1, 2026

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library
Published on: April 6, 2012
MicroRNA-296 functions as a tumor suppressor in breast cancer by targeting FGFR1 and regulating the Wnt/β-catenin
1Department of General Surgery Breast Ward, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, China. miaoyejz@126.com.
Objective:
Breast cancer (BC) is a common malignancy all over the world. However, the detailed mechanism underlying BC progression remains incompletely understood. MicroRNAs (miRNAs) have been observed to play crucial roles in tumorigenesis. The present study aimed to determine the expression and function of miR-296 in BC.
Patients And Methods:
MiR-296 expressions in BC tissue samples and cell lines were examined by quantitative Real Time-Polymerase Chain Reaction (qRT-PCR). After that, we performed functional assays, including MTT (3-(4,5-dimethyl thiazol-2-yl)-2,5-diphenyl tetrazolium bromide) assays and transwell assays, to show the functions of miR-296 in BC cell proliferation, invasion and migration. Immunological histological chemistry (IHC) assays were carried out to detect the expression levels of fibroblast growth factor receptor 1 (FGFR1) in BC tissue samples. Western blot was used to explore potential mechanisms of miR-296 in regulating BC progression. A Luciferase reporter assay was carried out to confirm the target gene of miR-296.
Results:
Quantitative Real Time-Polymerase Chain Reaction (qRT-PCR) results demonstrated a significant decrease of miR-296 expressions in BC when compared to the corresponding normal controls. In addition, the decreased miR-296 was correlated with the malignant phenotypes and poorer prognosis of BC patients. The functional assays indicated that miR-296 restoration could repress the proliferation, invasion and migration abilities of BC cells. Moreover, the results of the current study revealed that miR-296 exerted the repressive functions in BC cells via regulating FGFR1, the Wnt/β-catenin signaling pathway and EMT. Additionally, miR-296 up-regulation could inhibit in vivo BC cell growth.
Conclusions:
All these findings indicated that miR-296 exerted anti-BC functions, providing novel therapeutic strategies in BC treatment.
Insights
This study reveals that miR-296 is significantly decreased in breast cancer (BC) and acts as a tumor suppressor. Restoring miR-296 inhibits BC cell proliferation, invasion, and migration, offering potential therapeutic strategies.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Breast cancer (BC) is a prevalent global malignancy with incompletely understood progression mechanisms.
- MicroRNAs (miRNAs) are recognized for their critical roles in tumorigenesis.
- The specific role of miR-296 in BC development and progression requires further elucidation.
Purpose of the Study:
- To investigate the expression levels of miR-296 in breast cancer tissues and cell lines.
- To determine the functional impact of miR-296 on BC cell proliferation, invasion, and migration.
- To explore the underlying molecular mechanisms by which miR-296 influences BC progression.
Main Methods:
- Quantitative Real Time-Polymerase Chain Reaction (qRT-PCR) for miR-296 expression analysis.
- In vitro functional assays (MTT, Transwell) to assess proliferation, invasion, and migration.
- Immunohistochemistry (IHC), Western blot, and Luciferase reporter assays to investigate molecular targets and pathways (FGFR1, Wnt/β-catenin, EMT).
Main Results:
- miR-296 expression was significantly downregulated in BC tissues and cell lines compared to normal controls.
- Reduced miR-296 levels correlated with advanced malignant phenotypes and poorer patient prognosis.
- Restoration of miR-296 suppressed BC cell proliferation, invasion, and migration in vitro and inhibited tumor growth in vivo.
- miR-296 functions by regulating Fibroblast Growth Factor Receptor 1 (FGFR1), the Wnt/β-catenin signaling pathway, and Epithelial-Mesenchymal Transition (EMT).
Conclusions:
- miR-296 exhibits significant anti-tumor functions in breast cancer.
- The findings suggest miR-296 as a potential biomarker for BC prognosis and a novel therapeutic target for BC treatment.
Related Concept Videos
MicroRNAs
MicroRNAs
Canonical Wnt Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Mitogens and the Cell Cycle
Abnormal Proliferation

